Browse
Time

biotechnology

Trending
Today
Trending
Most Discussed
Most Viewed
Most Agreed
All Ideas
Today
This Week
This Month
All Time
MeasuredMove MeasuredMove IBB, 60, Long ,
IBB: IBB should push higher - 329 area in next month or so
40 0 5
IBB, 60 Long
IBB should push higher - 329 area in next month or so

Long some IBB calls at the 313 area. Expecting 320 area for the short term target where I will close half my position. Leave the other half to attempt a run up to 329 territory.

timwest timwest PRO IBB, D, Long ,
IBB: Biotech's 40% Bear Market is Over
1290 11 38
IBB, D Long
Biotech's 40% Bear Market is Over

There is one useful way to determine when a trend is over and that is using a 50% "speedline" of a move. The decline from $400 in $IBB, the IShares Nasdaq Biotechnology Index Fund back in July 2015 and then tumbled 40% to $240 on February 9th, 2016 and later retested $240 on June 27, 2016. The mid-point of that decline is $320 and a line drawn from ...

tradetraderson tradetraderson PIRS, 240, Long ,
PIRS: 4 HR MACD and RSI room to grow
38 1 6
PIRS, 240 Long
4 HR MACD and RSI room to grow

4 HR MACD and RSI room to grow

JacobFranklin JacobFranklin XBI, D, Short ,
XBI: XBI: Biotech slide back to channel bottom until End-July
32 0 5
XBI, D Short
XBI: Biotech slide back to channel bottom until End-July

XBI, LABU, BIB should slide to the bottom of the channel until End-July. See high moving-average divergence, reconvergence and channel pattern. Short unless something changes.

tradetraderson tradetraderson PIRS, D, Long ,
PIRS: cup and handle break out
34 0 2
PIRS, D Long
cup and handle break out

cup and handle break out. load up bears, you got this one, haha.

Wallstreet_CCCC Wallstreet_CCCC EKSO, M, Long ,
EKSO: EKSO Bionics
30 0 4
EKSO, M Long
EKSO Bionics

Research it. Could be a nice investment. Longing already from 1.00

trendsanati trendsanati SGMO, D, Long ,
SGMO: SGMO- Sangamo Daily
26 0 6
SGMO, D Long
SGMO- Sangamo Daily

Sangamo Daily Chart. Weekly Looking good NASDAQ:SGMO

matt.sulli42 matt.sulli42 CLRB, D, Long ,
CLRB: CLRB 1.44 Risk Reward
21 0 6
CLRB, D Long
CLRB 1.44 Risk Reward

Using fib support/resistance

Invictavis Invictavis GILD, W, Long ,
GILD: Gilead Biotech Aiming High
80 0 6
GILD, W Long
Gilead Biotech Aiming High

Although the ideas I share with you all revolve around currency pairs, I thought I'd share another specialty of mine: Biotech and pharma stock. If you're in the field, you may have already heard about Gilead having one of the best price to earning ratio of the major biotech companies. You may have also noticed the sharp decline that they experienced in the summer ...

MccaslinAndy MccaslinAndy ORPN, D, Long ,
ORPN: OPRN Long Position Chart
22 0 4
ORPN, D Long
OPRN Long Position Chart

A peek through the trend line looking good and Low float with any type of news catalyst could give this stock wings. I will use a break through $.94 as a confirmation reversal and will add to my position when passing $1.07. MACD cross on daily, RSI rising on daily. Volume will come from any exposure catalyst. A heck of a PT on this stock as well.

Saadey Saadey PLSE, D,
PLSE: Cash bleeding company on a bullish trend how far can this run?
59 0 2
PLSE, D
Cash bleeding company on a bullish trend how far can this run?

PLSE has been bleeding cash for a while now but it has attracted investments from two investors providing cash infusion to help it stay afloat on early February. This is when the stock broke out and has been trending up since then. Even though doom and gloom was predicted for PLSE here on Feb 23 2017 stock has moved up by $7 since then. Yesterday I was expecting a ...

ALUCARDDROL ALUCARDDROL AMRS, D,
AMRS: AMRS down - uknown reversal
33 0 2
AMRS, D
AMRS down - uknown reversal

Some support at .31 maybe. Big selloff by majority owner Temasek. large downturn

matt.sulli42 matt.sulli42 BIOL, W, Long ,
BIOL: will biol blow up? the road to 2.14
13 0 4
BIOL, W Long
will biol blow up? the road to 2.14

good fundamentals. hoping for reversal, to 2.14-2.2. solid entry, try 1.94/1.2 is 1.61 so around there is perfect for the correction up. best!

CalebDismuke CalebDismuke PRO TEVA, M,
TEVA: (TEVA)-Entering buy zone
46 0 1
TEVA, M
(TEVA)-Entering buy zone

No position yet. Refer to chart:) If you have any thoughts about this company, please leave in the comments:)

KasperAndersen KasperAndersen PRO LABU, D, Long ,
LABU: LABU - decent RR
99 0 8
LABU, D Long
LABU - decent RR

RR = 6.25

geniusbode geniusbode GILD, D, Long ,
GILD: Multiple +ive patterns
35 0 2
GILD, D Long
Multiple +ive patterns

1 trend retest 2 trend-based fibo. bounce zone 3 possible three bottoms (Super Pattern)

Sebas1231 Sebas1231 KBIO, W, Long ,
KBIO: $KBIO Long
14 0 2
KBIO, W Long
$KBIO Long

12.5.2016- $KBIO currently trading at 4.25. Potential once they receive PRV (Priority Review Voucher) for Benznidazole possibility for trading at $5-6. Stock jumped about $1 due to the Letter to Stakeholders by Dr. Cameron Durrant. I expect this stock to rise. Disclosure: I am long $KBIO SEE MORE: ...

matt.sulli42 matt.sulli42 TKAI, 15, Long ,
TKAI: tkai long risk/reward 1.64
36 0 6
TKAI, 15 Long
tkai long risk/reward 1.64

Tkai massive upside potential. In other words, buy between .99 and current price 1.06 and aim to get out in the 1.2's. Current price is the high point of first wave up (the XA)..price descended appropriately (1--> .618) for support, and moved higher between the 1.21 and 1.41 exetension of XA. The following downtrend in price should suggest a move upwards to at ...

123Show More Ideas
United States
United Kingdom
India
España
France
Italia
Polska
Brasil
Россия
Türkiye
Indonesia
日本
한국
Home Stock Screener Forex Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Account and Billing Sign Out